Why the study?
Does chronic vasodilator therapy improve heart size and functional status in a patient with cardiogenic shock and intractable left ventricular failure?
Population
1 patient with cardiogenic shock and intractable left ventricular failure due to coronary artery disease
Design
Case_report
Authors
Loading...
May support vasodilator trial in refractory LV failure; hypothesis-generating case report that leaves efficacy open in cardiogenic shock.
Does chronic vasodilator therapy improve heart size and functional status in a patient with cardiogenic shock and intractable left ventricular failure?
Chronic reduction of impedance to left ventricular ejection via vasodilator therapy may be a useful approach for severe left ventricular failure.
Jay N. Cohn (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: